Company: OSRH
Filing Date: 2025-04-22
Form Type: 10-K
Source: 0001213900-25-034116
Chunk: 787

Company: OSR Holdings, Inc.
Filing Date: 2025-04-22
Form: 10-K
Item: Item 1C
Chunk 787
---
 the Market Value.

Equity Participation Shares 

The Company agreed to
issue to the underwriters at the closing of the Initial Public Offering up to 34,500 Equity Participation Shares, including
over-allotment, which will be issued upon the completion of the Initial Business Combination. If the over-allotment option is not exercised
in full, the Equity Participation Shares will be reduced pro rata.

F-22

OSR HOLDINGS, INC.

(f/k/a Bellevue Life Sciences Acquisition Corp.) 

NOTES TO
CONSOLIDATED FINANCIAL STATEMENTS

DECEMBER 31, 2024

The Company complies with the requirements
of ASC 340-10-S99-1 and SEC SAB Topic 5A. Offering costs consist principally of professional and registration
fees incurred through the date of the consolidated financial statements that are related to the Initial Public Offering. Offering
costs directly attributable to the issuance of an equity contract to be classified in equity are recorded as a reduction in equity.
Offering costs for equity contracts that are classified as assets and liabilities are expensed immediately.

Rights 

Except in cases where the Company is not the surviving
company in a business combination, each holder of a right will automatically receive one-tenth (1/10) of a share of
common stock upon consummation of its initial business combination, even if the holder of a public right converted all shares of common
stock held by him, her or it in connection with the initial business combination or an amendment to the Company’s certificate of
incorporation with respect to its pre-business combination activities. In the event the Company will not be the surviving
company upon completion of its initial business combination, each holder of a right will be required to affirmatively convert his, her
or its rights in order to receive the one-tenth (1/10) of a share underlying each right upon consummation of the business
combination. No additional consideration will be required to be paid by a holder of rights in order to receive his, her or its additional
shares of common stock upon consummation of an initial business combination. The shares issuable upon exchange of the rights will be freely
tradable (except to the extent held by affiliates of the Company). If the Company enters into a definitive agreement for a business combination
in which the Company will not be the surviving entity, the definitive agreement will provide for